Your browser doesn't support javascript.
loading
Perivascular epitheliod cell tumors: Study of three gynecological cases.
Nicolás, Inmaculada; Fusté, Pere; Saco, Adela; Ordi, Jaume; Torné, Aureli.
Afiliação
  • Nicolás I; Institute Clinic of Gynecology, Obstetrics, and Neonatology, Hospital Clínic - Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain; Institut de Salut Global de Barcelona (ISGlobal), Barcelona, Spain. Electronic address: innipe@hotmail.com.
  • Fusté P; Institute Clinic of Gynecology, Obstetrics, and Neonatology, Hospital Clínic - Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.
  • Saco A; Department of Pathology, Hospital Clínic, University of Barcelona, Barcelona, Spain.
  • Ordi J; Department of Pathology, Hospital Clínic, University of Barcelona, Barcelona, Spain; Institut de Salut Global de Barcelona (ISGlobal), Barcelona, Spain.
  • Torné A; Institute Clinic of Gynecology, Obstetrics, and Neonatology, Hospital Clínic - Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.
Med Clin (Barc) ; 153(2): 83-87, 2019 07 19.
Article em En, Es | MEDLINE | ID: mdl-30827678
ABSTRACT
ANTECEDENTS Perivascular epitheliod cell tumor (PEComa) is a rare mesenchymal tumor. They are rare in the field of gynecology, which makes them difficult to consider as a possible diagnostic. We aim to contribute with our experience to ease clinical practice to others gynecologists. PATIENTS AND

METHODS:

We contribute to literature with three gynecological cases; uterine, vaginal and retroperitoneal PEComas.

RESULTS:

The uterine and vaginal PEComa, have required surgical treatment, and are free of disease at 9 and 5 months respectively. The retroperitoneal PEComa has recurred at 72 months of follow-up in form of retroperitoneal mass and pulmonary lymphangioleomyomatosis, continues treatment with sirolimus with good tolerance and partial response.

DISCUSSION:

Given the scarcity of cases, the literature consists of case reports and mini-reviews. Some authors have categorized the PEComas based on prognostic factors, but there is no agreement regarding the follow-up and treatment. 18F-FDG-PET/CT can help characterize these lesions. The surgery is the standard. In recurrent or malignant cases, there is a lack of evidence regarding chemotherapy and radiotherapy. New therapies with inhibitory m-TOR open a hopeful therapeutic window.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Retroperitoneais / Neoplasias Uterinas / Neoplasias Vaginais / Neoplasias de Células Epitelioides Perivasculares Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Adult / Aged / Female / Humans Idioma: En / Es Revista: Med Clin (Barc) Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Retroperitoneais / Neoplasias Uterinas / Neoplasias Vaginais / Neoplasias de Células Epitelioides Perivasculares Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Adult / Aged / Female / Humans Idioma: En / Es Revista: Med Clin (Barc) Ano de publicação: 2019 Tipo de documento: Article